Measuring the psychosocial health of adolescent and young adult (AYA) cancer survivors: a critical review by Clinton-McHarg, Tara et al.
REVIEW Open Access
Measuring the psychosocial health of adolescent
and young adult (AYA) cancer survivors:
a critical review
Tara Clinton-McHarg
1*, Mariko Carey
1, Rob Sanson-Fisher
1, Anthony Shakeshaft
2, Kathy Rainbird
3
Abstract
Background: Adolescent and young adult (AYA) cancer survivors require psychometrically rigorous measures to
assess their psychosocial well-being. Without methodologically adequate scales the accuracy of information
obtained on the prevalence of needs, predictors of risk, and the potential success of any interventions, can be
questioned. This review assessed the psychometric properties of measures designed specifically to identify the
psychosocial health of this unique population.
Methods: Medline, PsycINFO, CINAHL and EMBASE databases were searched to identify measures developed to
assess the psychosocial health of AYA cancer survivors. Searches were limited to the years 1998-2008. A search of
Medline revealed that the number of publications related to the assessment of psychosocial well-being in AYA
cancer survivors prior to this period were minimal. The psychometric properties of identified measures were
evaluated against pre-determined and generally accepted psychometric criteria including: reliability (internal
consistency and test-retest); validity (face, content, construct, and criterion); responsiveness; acceptability; and
feasibility.
Results: Seven quality of life measures met the inclusion criteria. No measures of unmet need were identified. All
seven measures reported adequate internal consistency, face, content, and construct validity. Test-retest reliability,
criterion (predictive) validity, responsiveness, acceptability, and feasibility were rarely examined.
Conclusions: There is a need to further evaluate the psychometric properties of existing quality of life measures
for AYA cancer survivors. Valid, reliable, and acceptable measures which can assess the psychosocial needs of this
population should also be developed.
Background
The global burden of adolescent and young adult cancer
Cancer is the leading disease-related cause of mortality
among adolescents and young adults (AYAs) resulting
in approximately 134,000 deaths worldwide, each year
[1]. AYAs have been broadly defined as young people
between the ages of 15 and 30 years [2-4]. Advances in
treatment mean that between 73-82% of AYA diagnosed
with cancer will now survive up to five years post-diag-
nosis [5-8]. Increasing survival rates mean that a greater
number of AYAs are living longer with the psychosocial
sequelae of their cancer diagnosis and its treatment
[7-10]. AYAs not only experience the wide range of phy-
sical, psychological, social and spiritual concerns of can-
cer survivors of all ages, but often have additional and
unique needs due to their cancer occurring during a
crucial stage of their personal and social development
[11-13].
Diversity of AYAs with cancer
Cancer survivorship has been defined as beginning from
the time of cancer diagnosis and includes people at var-
ious stages of the disease trajectory [14]. Although
grouped due to their unique developmental phase, AYA
cancer survivors represent a variety of socio-demo-
graphic backgrounds and cancer types. Some AYA sur-
vivors include students who live with their families,
while others are employed and live independently
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kaemia, invasive skin, genital, endocrine, brain or bone
cancer [4,6-8].
The acute psychosocial impact of cancer and its
treatment
The acute psychosocial impact of cancer and its treat-
ment may be substantial. Some AYAs experience physi-
cal side-effects such as pain, vomiting, and nausea
[17,18]. These physical symptoms can lead to high levels
of distress in young people, and can limit their ability to
engage in normal activities such as attending school or
work [15]. Participation in social events is often
restricted, and can mean that normal adolescent rites of
passage, such as the formation of identity and indepen-
dence are inadequately achieved [12,19,20]. This lack of
social interaction with peers can lead to feelings of isola-
tion and loneliness [11,12]. Side-effects of treatment
such as weight loss, hair loss or impaired physical devel-
opment can impact on perceived body image and can
contribute to loss of self-confidence [12,19,21]. Feelings
of hopelessness or anxiety have also been reported
[2,22]. A young person’s cancer diagnosis can also lead
to changes in family dynamics and impact on their rela-
tionships with parents, siblings, and significant others
[12,13,19].
The long-term psychosocial impact of cancer and its
treatment
Although some acute psychosocial consequences cease
once treatment is completed, others can have a long-
term impact on the psychosocial health of the survivor.
Compared with other young people their age, some
long-term AYA cancer survivors report poorer health
outcomes including higher rates of obesity, anxiety and
depression [20,23,24]. Some also experience cognitive
impairment which can impact on employment and edu-
cational attainment [25,26]. Concerns related to reduced
fertility and sexual dysfunction are also prevalent among
AYA cancer survivors [27,28].
Approaches to assessing the psychosocial health of
cancer survivors
The widely accepted World Health Organisation (WHO)
definition of health encompasses physical, mental and
social aspects of well-being, all of which are inextricably
linked and contribute to the global health of the indivi-
dual [6]. This necessitates the use of multi-dimensional
rather than uni-dimensional measures in order to
develop a comprehensive assessment of the health of an
individual [29]. Multi-dimensional measures of health
assess elements of physical, psychological, social, and
often spiritual well-being [29]. For cancer patients these
generally include measures of quality of life (QoL) and
perceived need. QoL measures assess an individual’s
perception of their current health status compared with
their health expectations [29,30]. In contrast, measures
of perceived need identify the needs individuals regard
as being unmet and the magnitude of help likely to be
required to address them [31,32]. While there are a
number of QoL and unmet needs tools for adult cancer
patients and survivors [33,34], few measures specific to
AYA cancer survivors have been identified [35-39].
Given the unique needs and experiences of this group,
psychosocial health measures developed and validated
with this population are needed to accurately assess
well-being.
Self-report rather than proxy measurement is generally
preferred for assessing psychosocial health. Although
proxy measurement may allow for the inclusion of
patients who are too ill or do not have the necessary lit-
eracy skills to participate alone, proxies can tend to base
their assessment on their impression of the patient,
rather than the actual situation [40,41]. Proxies are also
more inclined to focus on negative or extreme beha-
viour rather than positive or usual behaviour [41].
As well as being assessed by self-report and covering
broad psychosocial domains, measures designed to
assess the psychosocial well-being of AYA cancer survi-
vors need to be able to accurately reflect the unique
experiences of this population. Such measures should be
able to capture, and be sensitive to, changes in psycho-
social health across the disease trajectory so that the
effectiveness of interventions can be assessed [38]. Mea-
sures also need to be psychometrically robust so that
the prevalence of needs, and subgroups of young people
experiencing high needs, can be accurately identified
[38].
The aim of this review is to critically examine the psy-
chometric properties of multi-dimensional, self report
measures developed to assess the psychosocial health of
AYA cancer survivors.
Methods
Database search to identify relevant publications
Medline, PsychINFO, EMBASE and CINAHL databases
were searched to identify publications which described
the development of measures for assessing psychosocial
outcomes in AYA cancer survivors. These databases
were chosen as they all provide extensive coverage of
journals in the field of cancer research.
The database search was performed using the follow-
ing combinations of keywords: [neoplasm or cancer or
oncol*] and [adoles* or teenager or young adult or
youth] and [perceived need* or unmet need* or quality
of life or psychosocial or distress] and [develop* or
questionnaire or survey or measure or scale] and [psy-
chometric or reliability or validity or acceptability].
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guage and covered the last ten years from 1998 to 2008.
This timeframe was selected as a preliminary search of
Medline for all AYA related psychosocial research with-
out a year limitation revealed that there had been mini-
mal (< 17%) research output in field prior to 1998
(Figure 1), with only one publication before 1988 identi-
fied (one publication in 1976). Appraisal of these 23
publications revealed that no additional measures met
the inclusion criteria (outlined below) prior to 1998.
Duplicate publications, and publications which did not
specifically describe the development, psychometric
properties, or acceptability of a measure, were excluded.
Full text articles of the remaining publications were
obtained and reviewed to identify relevant measures.
Inclusion and exclusion of measures
While AYAs are commonly defined as 15-30 year olds,
definitions in the literature vary [2-4]. Therefore, an
inclusive approach was employed whereby scales devel-
oped for use with young people less than 15 years but
with an upper age limit between 15 and 30 years were
included (eg 12-20 years). Similarly, scales developed for
use with populations older than 15 years but less than
30 years were included (eg 16-28 years).
Measures which met all of the following criteria were
included in the study for coding: 1) quantitative; 2)
developed or validated in English; 3) multi-dimensional
and measured at least the following three psychosocial
domains: physical, psychological, and social; 4) cancer
specific; 5) assessed the well-being of patients or survi-
vors; 6) developed specifically for AYA or included
participants aged between15-30 years in their sample;
and 7) completed by self-report.
After identifying measures which met all of the inclu-
sion criteria, a second search of all databases by ‘mea-
sure name’ was performed to ensure that all
publications relating to each identified measure were
obtained.
Measure coding
Sample characteristics
In order to accurately assess the psychometric properties
of a measure, the sample used to develop the measure
should be described [42]. Measure development papers
were examined to determine whether the following sam-
ple characteristics were reported: a) inclusion and exclu-
sion criteria; b) setting; c) response rate; d) sample size;
e) age of participants; f) proportion of male and female
participants; g) cancer type; and h) cancer treatment
stage.
Psychometric properties
Measures were coded using pre-defined criteria consid-
ered important for scale development and health out-
come measurement [42-51]. The rigorousness of each
measure was assessed against criteria for: a) reliability;
b) validity; c) responsiveness; d) acceptability; e) feasibil-
ity; and f) cross-cultural adaptation, summarised in
Table 1.
Inter-rater agreement of coding existing measures
One reviewer used the inclusion and exclusion criteria
to identify measures for inclusion in the review. A sec-
ond reviewer cross-checked 15% of the measures, to
Figure 1 Number of publications related to the assessment of psychosocial well-being in AYA cancer survivors by year (1988-2008).
Clinton-McHarg et al. Health and Quality of Life Outcomes 2010, 8:25
http://www.hqlo.com/content/8/1/25
Page 3 of 13confirm their inclusion and exclusion status. The psy-
chometric criteria of all included measures were
reviewed by the first author and checked by the second.
Results
Database search to identify relevant publications
The initial search of the Medline, PsychINFO, EMBASE
and CINAHL databases identified a total of 552 publica-
tions related to assessing psychosocial outcomes in AYA
cancer survivors, with 436 papers having been published
in the last ten years (1998-2008). Of these 436 publica-
tions, 91 were duplicates and 146 did not describe the
development of a measure. The remaining 199 publica-
tions described the development of 204 measures.
197 measures did not meet the inclusion criteria (Fig-
ure 2), leaving seven measures to be included in the
psychometric review. These included the: 1) Adolescent
Quality of Life Instrument (AQoL)[35,36]; 2) Minneapo-
lis-Manchester Quality of Life Instrument (MMQL) -
Adolescent Form [52-54]; 3) Pediatric Quality of Life
Inventory (PedsQL) 3.0 Cancer Module Child and Ado-
lescent (C&A) Forms [55-58]; 4) Quality of Life - Can-
cer Survivors (QOL-CS) validation in childhood cancer
survivors [16]; 5) Pediatric Cancer Quality of Life Inven-
tory - 32 Short Form (PCQL-32) [59-61]; 6) Pediatric
C a n c e rQ u a l i t yo fL i f eI n v e n t o r y( P C Q L )M o d u l a r
Approach [62]; and 7) Perceived Illness Experience Scale
(PIE)[63,64].
Six measures were developed in the United States, one
was developed in the United Kingdom [63,64]. A
description of each measure’s domains and number of
items is presented in Table 2.
Table 1 Summary of psychometric properties and criteria used to review measures.
Psychometric Property Criteria
Reliability
Internal consistency
degree to which responses to all items on a scale are consistent [43]
Calculated correlations for total scale and domains [44]
- Cronbach’s alpha (a) > 0.70 [42,44]
- Kuder-Richardson 20 (KR-20) > 0.70 [42,44]
Test-retest
reproducibility of scores on a scale over repeated administrations [44]
Second administration within 2-14 days [46]
Calculated correlations for total scale, domains and items
[47]
- Cohen’s kappa coefficient () > 0.60 [44]
- Pearson correlation coefficient (r) > 0.70 [42,44]
- Intraclass correlation coefficient (ICC) > 0.70 [42,44]
Validity
Face
subjective assessment of whether a scale ‘appears’ to measure what it is
designed to measure [43]
Assessed as reasonable by those who administer/complete
it [43]
Content
degree to which the content of a scale is representative of the issue being
measured [43]
Reported item selection process [42,44]
Content assessed by experts [42,44]
Reported which aspects of the measure were revised [42,44]
Construct
way in which the internal structure of a scale relates to other conceptual
constructs [44]
Stated hypothesis about correlations between measures [44]
- Convergent (r) > 0.40 or Divergent (r) < 0.30 [48]
Calculated correlations between known-groups [42]
Performed factor analysis [44]
- Eigenvalues > 1 [49]
Criterion
how well a scale agrees with existing “gold standard” measurement of the
same issue [44]
Provided rationale for “gold standard” measure [44]
Stated type of criterion validity (concurrent or predictive)
[43]
Reported proportions [44,50]
- Sensitivity - % with issue correctly classified [44,50]
- Specificity - % without issue correctly classified [44,50]
Responsiveness
sensitivity of a scale to detect clinically important change in an outcome or
behaviour over time [42,50]
Reported floor/ceiling effects [51]
- < 5% of respondents have highest or lowest score [51]
Reported magnitude of change [42]
- Effect size > 0.5 [42,44,50]
Acceptability
level of burden placed on those who complete the measure [42]
Reported response rate, missing items, reading level, time to
complete [42]
Feasibility
level of burden placed on those who administer the measure [42]
Reported perceived time to administer, score, interpret [42]
Cross-cultural adaptation
conceptually, linguistically equivalent and display similar psychometric properties to
the original form [42]
Confirmed reliability and validity reflects the original version
[42]
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Overall, reporting of the sample accrual method and
the sociodemographic and clinical characteristics of
participants for each measure was comprehensive
(Table 3). Of the seven measures, three did not report
a response rate, one did not describe the inclusion and
exclusion criteria, and one measure did not report the
proportion of male and female participants or cancer
type.
All measures were developed using samples recruited
through hospitals or medical centres. Sample sizes
ranged from 41-291 participants, and age of participants
ranged from 5-28 years (mean range of 10.9-21.8 years).
The proportion of males and females was reasonably
equally distributed. For the majority of studies, the
greatest proportion of young people had been diagnosed
with Leukaemia. Cancer treatment stage ranged from
newly on treatment to 3-27 years post-diagnosis.
Psychometric properties
An overall summary of the psychometric properties
reported for each measure can be seen in Table 4.
Figure 2 Flowchart of the publication and measure inclusion and exclusion process. *Some publications described the development
ofmore than one measure. ** Development of some measures were reported across more than one publication.
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Internal consistency
Table 5 shows five measures had at least one domain with
poor internal consistency (Cronbach’sa l p h a s<0 . 7 0 ) ,
although their total scale internal consistency was ade-
quate. Two measures did not report internal consistency
for their domains (AQoL and PCQL Modular Approach),
however both the pain and nausea modules of the PCQL
Modular Approach had a Cronbach’s alpha > 0.70.
Test-retest
Two measures examined test-retest reliability. For both
studies, the second administration of the measure was
within the recommended time-frame of 2-14 days.
Only the MMQL Adolescent Form reported the intra-
class correlations for the two administrations, with five
of the seven domains having intraclass correlations
> 0.70.
Validity
Face/content
Table 6 shows six of the seven measures explored face
and content validity, with most involving both AYA can-
cer survivors and health care providers in their
development.
Construct/criterion
Five measures examined convergent or divergent validity
against other existing measures. Hypotheses were supported
by correlations > 0.40 or < 0.30. All of the measures were able
to discriminate between known groups. Factor analysis was
performed for two measures.N o n eo ft h em e a s u r e sw e r e
examined for criterion (concurrent or predictive) validity.
Responsiveness
Only two measures reported floor and ceiling effects
(Table 7). None of the measures reported their ability to
detect clinically important change over time.
Acceptability and feasibility
Table 7 also shows that the acceptability of the measures
was poorly described with only four measures reporting
missing items, and only three measures reporting their
reading level. The reading levels that were reported how-
ever were appropriate for the population group. Feasibility,
the time needed to administer, complete, and score the
measure, was not reported for any of the measures.
Cross-cultural adaptation
Two measures, the MMQL Adolescent Form and PedsQL
3.0 Cancer Module (C&A), have been adapted for cultures
other than the United States. For the culturally adapted
measures, similar reliability and validity to the original
measure was reported. The reliability of MMQL Adoles-
cent Form in an online format has also been verified.
Discussion
All of the psychosocial measures developed for AYA
cancer survivors included in this review showed high
total scale internal consistency. However, only one mea-
sure reported test-retest reliability coefficients, and
although intra-class correlations were reported for the
total scale and domains, no item-level test-retest corre-
lations were reported. This may present a problem
because while the same overall domain score may be
Table 2 Items and domains of measures included in the review.
Measure Items Domains Description Reference
AQoL
Adolescent Quality of Life
Instrument
16 5 normal activities, social/family interactions, health status, mood, meaning of
being ill
[35,36]
MMQL Adolescent Form
Minneapolis-Manchester Quality
of Life Instrument
46 7 physical, psychological, social, and cognitive functioning, body image, outlook on
life, intimate relations
[52-54]
PedsQL 3.0 Cancer Module
(C&A)
Pediatric Quality of Life Inventory
Child and Adolescent Forms
27 8 pain and hurt, nausea, procedural anxiety, treatment anxiety, worry, cognitive
problems, perceived physical appearance, communication
[55-58]
QOL-CS
Quality of Life-Cancer Survivors
41 4 physical, psychological (distress and fear), social, and spiritual well-being [16]
PCQL-32
Pediatric Cancer Quality of Life
Inventory - 32 Short Form
32 5 disease and treatment-related symptoms, physical, psychological, social, and
cognitive functioning
[59-61]
PCQL Modular Approach
Pediatric Cancer Quality of Life
Inventory Modular Approach
23 5 (core) physical, psychological, social, (modules) pain, nausea [62]
PIE
Perceived Illness Experience Scale
34 9 physical appearance, interference with activity, peer rejection, integration in
school, manipulation, parental behaviour, disclosure, preoccupation with illness,
impact of treatment
[63,64]
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Sample characteristics
Measure Inclusion/
exclusion
Setting Response
rate (%)
Sample
size (n)
Age
(yrs)
Gender
(%)
Cancer type
(%)
Cancer treatment
stage (%)
AQoL [35] Reported Hematology
/oncology clinic
95 75 9-20
mean
12.4
M (55)
F (45)
Leukaemia (50)
Bone/joint (17)
Lymphomas (9)
Neurological (9)
Hodgkin’s (5)
Other (9)
In treatment (55)
Pre or post treatment
(45)
MMQL
Adolescent
Forrm [52]
- Nine hospitals - 268 13-20.9
median
16.6
M (56)
F (44)
Leukaemia ALL (37)
Leukaemia AML (8)
Hodgkin’s (11)
Non-Hodgkin’s (11)
Brain (6)
Other (27)
On therapy (41)
Off therapy > 1 year
(59)
PedsQL 3.0
Cancer Module
(C&A) [55]
Reported Hematology/oncology center
and Center for Cancer and
Blood Diseases
- 220 5-18
mean
10.9
M (56)
F (44)
Leukaemia (50)
Brain (7)
Non-Hodgkin’s (6)
Hodgkin’s (3)
Wilm’s Tumor (6)
Other (28)
On treatment (54)
Off treatment < 1
year (18)
Off treatment > 1
year (28)
QOL-CS [16] Reported University medical center 53 176 16-28
mean
21.8
M (43)
F (57)
Leukaemia (30)
Brain/CNS (11)
Lymphoma (21)
Wilm’s Tumor (10)
Sarcomas (16)
Other (11)
3-27 yrs post-
diagnosis (100)
(average 13.3 yrs)
PCQL-32 [59] Reported Three pediatric cancer
centers
89.5 291 8-18
mean
11.78
M (61)
F (39)
Leukaemia ALL (44)
Leukaemia AML (6)
Leukaemia other (1)
Hodgkin’s (6)
Non-Hodgkin’s (9)
Other (34)
Newly on-treatment
(37)
Relapsed on
treatment (8)
Remission off-
treatment (11)
Long-term off-
treatment (44)
PCQL Modular
Approach [62]
Reported Three pediatric cancer
centers
89.5 291 8-18
mean
11.78
- - On treatment (45)
Off treatment (55)
PIE [63] Reported Children’s cancer unit - 41 8-24
mean
14.6
M (49)
F (51)
Leukaemia ALL (68)
Wilm’s Tumor (15)
Sarcomas (12)
Non-Hodgkin’s (5)
Maintenance
treatment (41)
Follow-up only (59)
*Data taken from the publication referenced in the Measure column unless otherwise referenced within the table.
Table 4 Summary of psychometric properties reported for each measure.
Measure Internal
consistency
Test-
retest
reliability
Face/content
validity
Construct validity Responsiveness Acceptability Cross-
cultural
Time ICC Convergent/
divergent
Known
groups
Factor
analysis
AQoL √√ - √ - √√ - √ -
MMQL Adolescent
Form
√√ √ √ √ √ -- - √
PedsQL 3.0 Cancer
Module (C&A)
√ -- √√ √ -- √√
QOL-CS √ -- - √√ √ - √ -
PCQL-32 √ -- √√ √ - √√ -
PCQL Modular
Approach
√ -- √ - √ - √√ -
PIE √ -- √√ √ -- √ -
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is possible that the individual item scores that make up
the domain score differ between administrations. This
may compromise the stability of the measure over time.
Face, content, and construct validity for all of the
measures were also psychometrically adequate. However,
no measures reported predictive validity. This may
reflect difficulties in identifying an appropriate ‘gold
standard’ with which to compare AYA perceptions of
their health, or difficulties related to longitudinal study
designs such as cost and participant attrition. The impli-
cation of this is that the ability of these measures to pre-
dict the risk of future health outcomes in AYA cancer
survivors remains unknown.
Reporting of measure responsiveness, acceptability and
feasibility was poor. No measures reported their ability
to detect clinically important change over time, raising
questions about the sensitivity of these instruments.
Reading level was only reported for three measures.
This is of concern because, due to their illness, AYA
Table 5 Coding of reliability criteria for each measure.
Measure Internal consistency Test-retest reliability
n Cronbach’s alpha a > 0.70 n Administration Period Intraclass correlation ICC > 0.70
AQoL [35] 75 Total scale = 0.77
No domains reported
17 Pre-weekend to post-weekend
Post-weekend to one month [36]
-
MMQL Adolescent Forrm [52] 397 Total scale = 0.78
6/7 domains > 0.70
Physical = 0.88
Psychological = 0.83
Social = 0.81
Cognitive = 0.89
Body image = 0.80
Outlook = 0.85
87 Two week interval Total scale = 0.71
5/7 domains > 0.70
Physical = 0.90
Cognitive = 0.88
Body image = 0.73
Outlook = 0.76
Relations = 0.81
PedsQL 3.0 Cancer Module (C&A) [55] 220 Total scale = 0.72
6/8 domains > 0.70
Pain and hurt = 0.70
Nausea = 0.79
Procedural Anxiety = 0.82
Treatment Anxiety = 0.79
Worry = 0.74
Cognitive = 0.76
-- -
QOL-CS [16] 176 Total Scale = 0.87
5/6 domains > 0.70
Physical = 0.81
Psychological = 0.82
Fears = 0.88
Social = 0.76
Spiritual = 0.78
-- -
PCQL-32 [60] 291 Total scale = 0.91
4/5 domains > 0.70
Disease/treatment = 0.83
Physical = 0.78
Psychological = 0.76
Cognitive = 0.81
-- -
PCQL Modular Approach [62] 281 Total scale = 0.83
No domains reported
All modules > 0.70
Pain = 0.82
Nausea = 0.71
-- -
PIE [63] 41 Total scale = 0.84
2/9 domains > 0.70
Manipulation = 0.70
Parental behaviour = 0.73
Total scale = 0.91
4/9 domains > 0.70
Peer rejection = 0.79
Parental behaviour = 0.71
Preoccupation illness = 0.73
Food = 0.70 [64]
41 - -
*Data taken from the publication referenced in the Measure column unless otherwise referenced within the table.
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Measure Face/Content validity Construct validity
Convergent r > 0.40
Divergent r < 0.30
Known groups (discriminate) Factor Analysis
Eigenvalues > 1
AQoL [35] Assessed by survivors
Review of literature
Item wording, redundancy
Pilot test (n = 7)
- Receiving treatment (n = 41)
Not receiving treatment (n = 34)
P = 0.000
6 factors
Represented
66.5% of
variance
MMQL Adolescent
Forrm [52]
Assessed by survivors
Focus group (n = 20)
Interviews (n = 20)
Pilot test 1
st (n = 10) 2
nd (n = 10)
Child Health
Questionnaire - Child
Form
Hypotheses supported
42 correlations > 0.40
Healthy adolescents (n = 129)
On therapy (n = 110)
Off therapy (n = 158)
P < 0.05 for 4 domains
-
PedsQL 3.0 Cancer
Module (C&A) [55]
Adapted from Pediatric
Cancer Quality of Life Inventory (PCQL),
PedsQL 1.0 Cancer Module, and PedsQL
PedsQL 4.0 Generic Core
Scale
PedsQL Multidimensional
Fatigue Scale
Hypotheses supported
34 correlations > 0.40
On treatment (n = 106)
Off treatment < 1 year (n = 41)
Off treatment > 1 year (n = 73)
P < 0.05 for 3 domains
-
QOL-CS [16] - Cancer Specific Worry
Scale
Psychosocial Worry Scale
General Health Worry
Scale
Hypotheses supported
9 correlations > 0.40
Other condition (Y = 28, N = 148)
After-effects (Y = 86, N = 90)
Income (< $25 K = 36, > $25 K = 127)
Gender (F = 101, M = 75)
Marital status
P < 0.05 for 5 factors
6 factors
Represented
56.2% of
variance
PCQL-32 [60] Assessed by survivors
Review of literature
Interviews and pilot test
Item wording, relevance, redundancy,
reduction [59]
Children’ Depression
Inventory
Stait-Trait Anxiety
Inventory-32 (Child)
Social Support Scale
(Child/Adoles)
Self-Perception Profile
(Child/Adoles)
Child Behaviour Checklist
Hypotheses Supported
10 correlations > 0.40
15 correlations < 0.30
On treatment (n = 125)
Off treatment (n = 156)
P < 0.05 for total scale and 3 domains
-
PCQL Modular
Approach [62]
Adapted from the PCQL long form and
PCQL-32
- On treatment (n = 125)
Off treatment (n = 156)
P < 0.05 for the core and symptom
modules
-
PIE [63] Assessed by survivors
Interviews (n = 15)
Item reduction
Rotterdam Symptom
Checklist
Functional Disability
Inventory
Restrictions Scale
Psychological Symptoms
Hypotheses Supported
9 correlations > 0.40
20 correlations < 0.30
Younger children
Older Children
Maintenance treatment
Completed treatment
P < 0.05 for 2 domains
-
SF-36
Functional Evaluation
Scale
Hypotheses Supported
38 correlations > 0.40
44 correlations < 0.30
[64]
*Data taken from the publication referenced in the Measure column unless otherwise referenced within the table.
Clinton-McHarg et al. Health and Quality of Life Outcomes 2010, 8:25
http://www.hqlo.com/content/8/1/25
Page 9 of 13cancer survivors may have missed a significant propor-
tion of their schooling [15,65]. Poor readability and
comprehension of items may lead to misinterpretation,
or missing items altogether, thereby reducing the accu-
racy of results obtained.
Given the absence of findings regarding either test-ret-
est reliability, or responsiveness and acceptability for all
of the identified measures, it is difficult to recommend
any of them as outcome measures for use in interven-
tion studies. For some, the unknown ability of the mea-
sure to remain stable over time would make it difficult
to assess whether changes on the measure were due to
the intervention alone. For others, the undetermined
responsiveness of the instrument would mean that if no
change was observed, this could be either due to lack of
sensitivity in the measure or lack of an intervention
effect.
However, both the MMQL Adolescent Form and the
PCQL-32 show promise as measures of quality of life
for AYAs. The MMQL Adolescent Form showed good
internal consistency (6/7 domains a > 0.70) and test-ret-
est reliability at the domain level (5/7 domains ICC >
0.70). The PCQL-32 also reported good internal consis-
tency, validity and acceptability. Further psychometric
testing to establish item-level test-retest reliability and
responsiveness for the MMQL, and test-retest reliability
for the PCQL-32, is needed.
A literature search did not reveal any other reviews
of psychosocial measures for AYA cancer survivors.
However, the results of the current review appear to
be commensurate with the findings of similar reviews
of measures developed for use with other cancer popu-
lations. A review of quality of life instruments for use
with adult cancer survivors [33]found that, of the nine
measures identified, readability, acceptability, feasibility
and predictive validity were rarely or (as in the case of
predictive validity) never examined. Of the four mea-
sures that examined test-retest reliability, only one
reported acceptable test-retest coefficients [33]. A
comparable review of needs assessment instruments
for cancer patients and their families also found that
reading levels and sensitivity to change were poorly
examined [34]. Similar trends were reported in a sys-
tematic review of instruments for the assessment of
fatigue in cancer patients [66]. Of 14 instruments iden-
tified, only six were examined for test-retest reliability,
and only seven analysed responsiveness [66]. In a
review of cancer symptom assessment instruments,
only one out of 21 identified instruments reported pre-
dictive validity [67].
It is interesting to note that all of the multidimen-
sional measures included in this review assessed quality
of life in AYA cancer survivors. No measures of per-
ceived need were identified. Using only measures of
Table 7 Coding of responsiveness, acceptability and feasibility for each measure.
Measure Responsiveness Acceptability Cross-cultural
AQoL [35] - Response rate 95%
Reading level Flesch-Kincaid grade
6.2 [36]
-
MMQL Adolescent Forrm [52] - - Anglicised for UK and shortened to the MMQL-29
[53]
Internal consistency in an online format [54]
Reliability and validity demonstrated
PedsQL 3.0 Cancer Module
(C&A) [55]
- Missing items 0.5% Initial development in English and Spanish [55]
Adapted to Brazilian, German, and Australian
cultures [56-58]
Reliability and validity demonstrated
QOL-CS [16] - Response rate 53% -
PCQL-32 [61] On treatment
Floor 1.6-20.0%
Ceiling 0%
Response rate 89.5%
Missing items 0.01%
-
Off treatment
Floor 1.9-32.7%
Ceiling 0%
PCQL Modular Approach [62] On treatment
Floor 0-3.1%
Ceiling 3.1-22.9%
Response rate 95%
Missing items 0.01%
-
Off treatment
Floor 0-1.9%
Ceiling 10.6-35.6%
Reading level Flesch-Kincaid
grade 1.8
PIE [63] - Reading level Flesch-Kincaid
grade 7
-
*Data taken from the publication referenced in the Measure column unless otherwise referenced within the table.
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about the type of help AYA cancer survivors would like,
rather than allowing individuals to specifically indicate
areas in which they would like to receive help [31,32].
In addition, all of the samples used in the development
of these measures were recruited through hospitals or
medical centres. The extent to which these samples
were representative of the broader AYA population,
including under-served AYA populations such as those
living in rural or remote areas, is unknown.
Limitations
The literature search for this review was conducted
using four online publication databases, and the grey lit-
erature was not included. Therefore, it is possible that
some relevant measures were missed. However, it is
likely that measures identified in this review are likely to
be of the best quality as they have been published in
peer-reviewed, indexed journals. The step of conducting
a second search by measure name would have also mini-
mised the chance that publications relating to relevant
measures were overlooked.
The definition of AYA cancer survivors used in this
review was young people between the ages of 15 and 30
years. However as a group, the AYA population is not
defined well in literature, and ranges from 12 up to 40
years [2-4]. To overcome this discrepancy, any measures
developed for an age cohort which overlapped the 15 to
30 year old age bracket were included. This may mean
that some of the results reported in this review reflect
measure performance with individuals outside the AYA
definition used for this review.
Conclusions
There is a general need to improve the psychometric
properties of existing quality of life measures to assess
the psychosocial well-beingo fA Y Ac a n c e rs u r v i v o r s .
The MMQL Adolescent Form and the PCQL-32 have
provided the most evidence for their psychometric prop-
erties to date. However, without sufficiently robust mea-
sures the prevalence of any reported concerns or needs,
and the effectiveness of interventions which aim to ame-
liorate them, remains uncertain. Studies which focus on
the test-retest reliability, responsiveness, acceptability,
feasibility, and predictive validity of the measure are
essential. Development of a psychometrically rigorous
measure of perceived needs for use with AYA cancer
survivors is warranted.
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